318 related articles for article (PubMed ID: 29607054)
1. Non-alcoholic steatofibrosis (NASF) can independently predict mortality in patients with non-alcoholic fatty liver disease (NAFLD).
Golabi P; Stepanova M; Pham HT; Cable R; Rafiq N; Bush H; Gogoll T; Younossi ZM
BMJ Open Gastroenterol; 2018; 5(1):e000198. PubMed ID: 29607054
[TBL] [Abstract][Full Text] [Related]
2. Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States.
Kim D; Kim WR; Kim HJ; Therneau TM
Hepatology; 2013 Apr; 57(4):1357-65. PubMed ID: 23175136
[TBL] [Abstract][Full Text] [Related]
3. Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver disease.
Younossi ZM; Stepanova M; Rafiq N; Henry L; Loomba R; Makhlouf H; Goodman Z
Hepatol Commun; 2017 Jul; 1(5):421-428. PubMed ID: 29404470
[TBL] [Abstract][Full Text] [Related]
4. NAFLD fibrosis score: a prognostic predictor for mortality and liver complications among NAFLD patients.
Treeprasertsuk S; Björnsson E; Enders F; Suwanwalaikorn S; Lindor KD
World J Gastroenterol; 2013 Feb; 19(8):1219-29. PubMed ID: 23482703
[TBL] [Abstract][Full Text] [Related]
5. High NAFLD fibrosis score in non-alcoholic fatty liver disease as a predictor of carotid plaque development: a retrospective cohort study based on regular health check-up data in China.
Yu X; Chen C; Guo Y; Tong Y; Zhao Y; Wu L; Sun X; Wu X; Song Z
Ann Med; 2021 Dec; 53(1):1621-1631. PubMed ID: 34498502
[TBL] [Abstract][Full Text] [Related]
6. Muscle strength, but not body mass index, is associated with mortality in patients with non-alcoholic fatty liver disease.
Charatcharoenwitthaya P; Karaketklang K; Aekplakorn W
J Cachexia Sarcopenia Muscle; 2022 Oct; 13(5):2393-2404. PubMed ID: 36017777
[TBL] [Abstract][Full Text] [Related]
7. Single non-invasive model to diagnose non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
Otgonsuren M; Estep MJ; Hossain N; Younossi E; Frost S; Henry L; Hunt S; Fang Y; Goodman Z; Younossi ZM
J Gastroenterol Hepatol; 2014 Dec; 29(12):2006-13. PubMed ID: 25039333
[TBL] [Abstract][Full Text] [Related]
8. The Repeatedly Elevated Fatty Liver Index Is Associated With Increased Mortality: A Population-Based Cohort Study.
Lee CH; Han KD; Kim DH; Kwak MS
Front Endocrinol (Lausanne); 2021; 12():638615. PubMed ID: 33776934
[TBL] [Abstract][Full Text] [Related]
9. Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease.
Golabi P; Gerber L; Paik JM; Deshpande R; de Avila L; Younossi ZM
JHEP Rep; 2020 Dec; 2(6):100171. PubMed ID: 32964202
[TBL] [Abstract][Full Text] [Related]
10. Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease.
Younossi ZM; Paik JM; Stepanova M; Ong J; Alqahtani S; Henry L
J Hepatol; 2024 May; 80(5):694-701. PubMed ID: 38286339
[TBL] [Abstract][Full Text] [Related]
11. The impact of non-alcoholic fatty liver disease and liver fibrosis on adverse clinical outcomes and mortality in patients with chronic kidney disease: a prospective cohort study using the UK Biobank.
Hydes TJ; Kennedy OJ; Buchanan R; Cuthbertson DJ; Parkes J; Fraser SDS; Roderick P
BMC Med; 2023 May; 21(1):185. PubMed ID: 37198624
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive fibrosis scoring systems can predict future metabolic complications and overall mortality in non-alcoholic fatty liver disease (NAFLD).
Önnerhag K; Hartman H; Nilsson PM; Lindgren S
Scand J Gastroenterol; 2019 Mar; 54(3):328-334. PubMed ID: 30907181
[No Abstract] [Full Text] [Related]
13. Non-alcoholic fatty liver disease in children and young adults is associated with increased long-term mortality.
Simon TG; Roelstraete B; Hartjes K; Shah U; Khalili H; Arnell H; Ludvigsson JF
J Hepatol; 2021 Nov; 75(5):1034-1041. PubMed ID: 34224779
[TBL] [Abstract][Full Text] [Related]
14. Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort.
Simon TG; Roelstraete B; Hagström H; Sundström J; Ludvigsson JF
Gut; 2022 Sep; 71(9):1867-1875. PubMed ID: 34489307
[TBL] [Abstract][Full Text] [Related]
15. Histopathological differences in patients with biopsy-proven non-alcoholic fatty liver disease with and without type 2 diabetes.
Aller de la Fuente R; Mora Cuadrado N; Tafur C; López Gómez JJ; Gómez de la Cuesta S; García Sánchez MC; Antolin Melero B; de Luis Román DA
Endocrinol Diabetes Nutr (Engl Ed); 2018; 65(6):354-360. PubMed ID: 29477355
[TBL] [Abstract][Full Text] [Related]
16. Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort.
Simon TG; Roelstraete B; Khalili H; Hagström H; Ludvigsson JF
Gut; 2021 Jul; 70(7):1375-1382. PubMed ID: 33037056
[TBL] [Abstract][Full Text] [Related]
17. Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD).
Stepanova M; Rafiq N; Makhlouf H; Agrawal R; Kaur I; Younoszai Z; McCullough A; Goodman Z; Younossi ZM
Dig Dis Sci; 2013 Oct; 58(10):3017-23. PubMed ID: 23775317
[TBL] [Abstract][Full Text] [Related]
18. The burden of NAFLD in type 2 diabetic subjects from the general population: A Nationwide population-based follow-up study (NASHCO).
Nabi O; Boursier J; Lapidus N; Mathurin P; de Ledinghen V; Petit JM; Goldberg M; Zins M; Lacombe K; Serfaty L
Liver Int; 2022 Mar; 42(3):595-606. PubMed ID: 35066992
[TBL] [Abstract][Full Text] [Related]
19. Waist-to-calf circumstance ratio is an independent predictor of hepatic steatosis and fibrosis in patients with type 2 diabetes.
Choe EY; Lee YH; Choi YJ; Huh BW; Lee BW; Kim SK; Kang ES; Cha BS; Lee EJ; Huh KB; Younossi ZM
J Gastroenterol Hepatol; 2018 May; 33(5):1082-1091. PubMed ID: 28990251
[TBL] [Abstract][Full Text] [Related]
20. Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease.
Younossi ZM; Stepanova M; Ong J; Yilmaz Y; Duseja A; Eguchi Y; El Kassas M; Castellanos-Fernandez M; George J; Jacobson IM; Bugianesi E; Wong VW; Arrese M; de Ledinghen V; Romero-Gomez M; Mendez-Sanchez N; Ahmed A; Wong R; Papatheodoridis G; Serfaty L; Younossi I; Nader F; Ziayee M; Afendy A;
Clin Gastroenterol Hepatol; 2019 Jul; 17(8):1625-1633.e1. PubMed ID: 30476585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
